Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Techne Corp (TECH)

Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bio-Techne Corp 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 USA

www.bio-techne.com Employees: 3,100 P: 612-379-8854 F: 612-656-4400

Sector:

Medical

Description:

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.

Key Statistics

Overview:

Market Capitalization, $K 10,236,914
Enterprise Value, $K 10,420,724
Shares Outstanding, K 155,813
Annual Sales, $ 1,220 M
Annual Net Income, $ 73,400 K
Last Quarter Sales, $ 286,560 K
Last Quarter Net Income, $ 38,190 K
EBIT, $ 109,930 K
EBITDA, $ 219,830 K
60-Month Beta 1.47
% of Insider Shareholders 1.30%
% of Institutional Shareholders 98.95%
Float, K 153,787
% Float 98.70%
Short Interest 9,415
Short Float 6.04%
Short Volume Ratio 0.80

Growth:

1-Year Return -9.21%
3-Year Return -18.29%
5-Year Return -25.34%
5-Year Revenue Growth 65.11%
5-Year Earnings Growth 76.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.42 on 11/05/25
Next Earnings Date 02/04/26 [--]
Earnings Per Share ttm 1.72
EPS Growth vs. Prev Qtr -29.41%
EPS Growth vs. Prev Year -2.70%
Annual Dividend & Yield 0.32 (0.49%)
Annual Dividend & Yield (Fwd) 0.32 (0.49%)
Most Recent Dividend 0.080 on 11/17/25
Next Ex-Dividends Date 11/17/25
Dividend Payable Date 11/28/25
Dividend Payout Ratio 18.57%
Most Recent Split 4-1 on 11/30/22

TECH Ratios

Ratio
Price/Earnings ttm 38.20
Price/Earnings forward 39.39
Price/Earnings to Growth 4.53
Return-on-Equity % 13.59%
Return-on-Assets % 10.43%
Profit Margin % 6.02%
Debt/Equity 0.15
Price/Sales 8.39
Price/Cash Flow 26.87
Price/Book 5.21
Book Value/Share 12.62
Interest Coverage 12.57

TECH Dividends

Date Value
11/17/25 $0.0800
08/18/25 $0.0800
05/19/25 $0.0800
02/14/25 $0.0800
11/08/24 $0.0800
08/19/24 $0.0800
05/10/24 $0.0800
02/09/24 $0.0800
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar